Design Therapeutics, Inc.DSGN
Price (close)
$12.12
Market cap
$758.5M
P/E
—
Revenue (TTM)
$0
Net income
-$70.8M
Dividend yield
—
1-year total return
98.4%
Net margin
—
Revenue growth
—
Debt / equity
—
What Design Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $226,000 | — | — | — | $0 | $0 |
| Net income | -$8.3M | -$35.5M | -$63.3M | -$66.9M | -$49.6M | -$69.8M |
| Free cash flow | -$8.7M | -$30.9M | -$52.2M | -$58.8M | -$43.4M | -$54.6M |
More on DSGN.
- Design Therapeutics, Inc. summary
- Design Therapeutics, Inc. financial statements
- Design Therapeutics, Inc. key metrics
- Design Therapeutics, Inc. health scores and style box
- Design Therapeutics, Inc. earnings
- Design Therapeutics, Inc. dividends
- Design Therapeutics, Inc. valuation
- Design Therapeutics, Inc. ownership and insiders
- Design Therapeutics, Inc. peers
Figures from Design Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.